|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/39591 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K2317/14 | (2013.01) | ||
| C07K2319/55 | (2013.01) |
| (11) | Number of the document | 3494992 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18200555.3 |
| Date of filing the European patent application | 2013-12-19 | |
| (97) | Date of publication of the European application | 2019-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261740111 P | 2012-12-20 | US |
| (72) |
HUNTER, Alan , US
LINKE, Thomas , US
PABST, Tim , US
WENDELER, Michaela , US
WANG, Xiangyang , US
THOMPSON, Chris , US
XI, Guoling , US
FULTON, Andrew , US
|
| (73) |
Medimmune Limited ,
Milstein Building
Granta Park, Cambridge CB21 6GH,
GB
|
| (54) | REFOLDING AND PURIFICATION OF MOXETUMOMAB PASUDOTOX |
| REFOLDING AND PURIFICATION OF MOXETUMOMAB PASUDOTOX |